| FIDELITY FUNDS-TECHNOLOGY OPPORTUNITIES Y-ACC-EUR (HEDGED) | RVI TECNOLOGÍA | 43,76% | 76,30% | 37,76% | · |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | RVI BIOTECNOLOGÍA | 43,76% | 16,89% | -23,38% | · |
| AB FCP I-EMERGING MARKETS GROWTH PORTFOLIO A HKD | RVI EMERGENTES CRECIMIENTO | 43,75% | 65,39% | 31,87% | 101,08% |
| DWS ESG BIOTECH TFC | RVI BIOTECNOLOGÍA | 43,74% | 50,42% | 39,70% | · |
| GOLDMAN SACHS US SMALL CAP CORE EQUITY PORTFOLIO I (SNAP) USD DIS | RVI USA SMALL/MID CAP | 43,74% | 72,62% | 75,42% | 191,25% |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 43,74% | 17,54% | -22,28% | · |
| BNP PARIBAS JAPAN EQUITY N EUR CAP | RVI JAPÓN | 43,73% | · | · | · |
| JANUS HENDERSON HF - JAPANESE SMALLER COMPANIES A2 USD | RVI JAPÓN SMALL/MID CAP | 43,73% | 54,59% | 45,60% | 125,95% |
| ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE IT USD | RVI TECNOLOGÍA | 43,72% | 75,08% | 46,87% | · |
| NEUBERGER BERMAN EMERGING MARKETS EQUITY CAD I DIS | RVI EMERGENTES | 43,72% | 89,21% | 48,35% | · |
